✦ LIBER ✦

Etanercept for Steroid-Refractory Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

✍ Scribed by J.S. Park; S.H. Jeong; M.S. Ahn

Book ID: 116282512
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 47 KB
Volume: 17
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2010.12.577

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acute graft-versus-host disease followin

Acute graft-versus-host disease following hematopoietic stem-cell transplantation

✍ STEPHANIE W. HU; JONATHAN COTLIAR 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB

Infliximab for steroid refractory or dep

Infliximab for steroid refractory or dependent gastrointestinal acute graft-versus-host disease in children after allogeneic hematopoietic stem cell transplantation

✍ Jun Yang; Daniel Ka Leung Cheuk; Shau Yin Ha; Alan Kwok Shing Chiang; Tsz Leung 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB

Immunosuppressive treatment of severe ac

Immunosuppressive treatment of severe acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

✍ I.P Zupan; S Zver; J Pretnar 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Sirolimus as Primary Treatment of Acute

Sirolimus as Primary Treatment of Acute Graft-versus-Host Disease following Allogeneic Hematopoietic Cell Transplantation

✍ Joseph Pidala; Jongphil Kim; Claudio Anasetti 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Recombinant human soluble tumor necrosis

Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation

✍ Alessandro Busca; Franco Locatelli; Filippo Marmont; Cristina Ceretto; Michele F 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 2 views

## Abstract Etanercept is a recombinant human soluble tumor necrosis factor (TNF‐α) receptor fusion protein that inhibits TNF‐α, a major mediator in the pathogenesis of graft‐versus‐host disease (GVHD). The purpose of our study was to evaluate the safety and efficacy of etanercept therapy in 21 pat

Allogeneic stem cell transplantation as

Allogeneic stem cell transplantation as treatment for heavily treated, refractory acute graft-versus-host disease after HLA-mismatched stem cell transplantation

✍ Kazuhiro Ikegame; Satoshi Yoshihara; Yuki Taniguchi; Katsuji Kaida; Takayuki Ino 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 214 KB